MorphoSys und Galapagos geben den Beginn der GECKO Phase 2-Studie mit MOR106 bei Patienten mit atopischer Dermatitis bekannt
Die MorphoSys AG (Frankfurt: MOR; Prime Standard Segment, TecDAX; NASDAQ: MOR), Galapagos NV (Euronext & NASDAQ: GLPG) u…
Die MorphoSys AG (Frankfurt: MOR; Prime Standard Segment, TecDAX; NASDAQ: MOR), Galapagos NV (Euronext & NASDAQ: GLPG) u…
Segmentation Analysis: The Global Pediatric Vaccines Market has been segmented on the basis of type, technology, disea…
Major Key Players: Leading players profiled in the cancer immunotherapy market include Spectrum Pharmaceuticals, Inc.…
Das auf Immunonkologie spezialisierte biopharmazeutische Unternehmen Apogenix AG gab heute bekannt, dass Dr. Oliver Hill…
Neue Analysen von IQVIA zur Arzneimittelversorgung im Jahr 2018 zeigen ein Umsatzwachstum des Pharmagesamtmarktes im mi…
Atopic Dermatitis Market – Overview Atopic dermatitis is a disease that affects the people with super sensitive skin.…
Global Pediatric Vaccines Market Segmentation: The Global Pediatric Vaccines Market has been segmented on the basis of…
Global Pediatric Vaccines Market Segmentation: The Global Pediatric Vaccines Market has been segmented on the basis of…
According to Non-Hodgkin’s Lymphoma Classification Project (CDC), peripheral T-cell lymphoma patients constitute 6%-7% o…
Global Breast Cancer Market - Segmentation Global breast cancer market is segmented on the basis of type into invasive…